Literature DB >> 17226068

Molecular characterization of infectious bursal disease virus (IBDV): diversity of very virulent IBDV in Tanzania.

C J Kasanga1, T Yamaguchi, P N Wambura, A D Maeda-Machang'u, K Ohya, H Fukushi.   

Abstract

Nucleotide sequences of the VP2 hypervariable region (VP2-HVR) of 14 infectious bursal disease viruses (IBDVs) isolated in Tanzania from 2001 to 2004 were determined. Phylogenetic analysis showed that the isolates diverged into two genotypes and belonged to the very virulent (VV) type. In the phylogenetic tree, strains in one genotype clustered in a distinct group and were closely related to some strains isolated in western Africa, with nucleotide similarities of 96.1-96.8%, while strains in another genotype were clustered within the European/Asian VV type with nucleotide similarities ranging from 97.5 to 99.3%. Both genotypes were widely distributed throughout Tanzania, and had conserved putative virulence marker amino acids (aa) at positions 222(A), 242(I), 256(I), 294(I) and 299(S). Our findings demonstrate for the first time the existence of both African and European/Asian VV-IBDV variants in Tanzania.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17226068     DOI: 10.1007/s00705-006-0898-5

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  9 in total

1.  Molecular epizootiology of infectious bursal disease (IBD) in Korea.

Authors:  Woo-Jin Jeon; Kang-Seuk Choi; Dong-Woo Lee; Eun-Kyoung Lee; Sang-Ho Cha; Sun-Hee Cho; Jun-Hun Kwon; Yeo-sung Yoon; Sun-Joong Kim; Jae-Hong Kim; Hyuk-Joon Kwon
Journal:  Virus Genes       Date:  2009-09-01       Impact factor: 2.332

2.  Molecular epidemiology of infectious bursal disease viruses isolated from Southern China during the years 2000-2010.

Authors:  Xiumiao He; Ping Wei; Xiuying Yang; Dingming Guan; Guijun Wang; Aijian Qin
Journal:  Virus Genes       Date:  2012-05-26       Impact factor: 2.332

3.  Detection of infectious bursal disease virus (IBDV) genome in free-living pigeon and guinea fowl in Africa suggests involvement of wild birds in the epidemiology of IBDV.

Authors:  Christopher J Kasanga; Tsuyoshi Yamaguchi; Philemon N Wambura; Hetron M Munang'andu; Kenji Ohya; Hideto Fukushi
Journal:  Virus Genes       Date:  2008-03-15       Impact factor: 2.332

4.  Molecular characteristic of VP2 gene of infectious bursal disease viruses isolated from a farm in two decades.

Authors:  Yinju Li; Tingcai Wu; Xiangchao Cheng; Chunjie Zhang
Journal:  Virus Genes       Date:  2009-04-02       Impact factor: 2.332

5.  Classification of infectious bursal disease virus into genogroups.

Authors:  Linda O Michel; Daral J Jackwood
Journal:  Arch Virol       Date:  2017-08-19       Impact factor: 2.574

Review 6.  Infectious bursal disease virus in poultry: current status and future prospects.

Authors:  Tamiru Negash Alkie; Silke Rautenschlein
Journal:  Vet Med (Auckl)       Date:  2016-01-19

7.  Efficacy of live attenuated, vector and immune complex infectious bursal disease virus (IBDV) vaccines in preventing field strain bursa colonization: A European multicentric study.

Authors:  Gema Ramon; Matteo Legnardi; Mattia Cecchinato; Christophe Cazaban; Claudia Maria Tucciarone; Laura Fiorentini; Lorenzo Gambi; Tamas Mato; Giacomo Berto; Kostas Koutoulis; Giovanni Franzo
Journal:  Front Vet Sci       Date:  2022-09-12

8.  Genetic characterisation of infectious bursal disease virus isolates in Ethiopia.

Authors:  Shiferaw Jenberie; Stacey E Lynch; Fekadu Kebede; Robert M Christley; Esayas Gelaye; Haileleul Negussie; Kassahun Asmare; Gelagay Ayelet
Journal:  Acta Trop       Date:  2013-10-18       Impact factor: 3.112

9.  Sequence-based comparison of field and vaccine strains of infectious bursal disease virus in Ethiopia reveals an amino acid mismatch in the immunodominant VP2 protein.

Authors:  Dereje Shegu; Teshale Sori; Asaminew Tesfaye; Alebachew Belay; Hawa Mohammed; Teferi Degefa; Belayneh Getachew; Takele Abayneh; Esayas Gelaye
Journal:  Arch Virol       Date:  2020-04-13       Impact factor: 2.574

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.